Tucson Business Radio

TMBS E101: Nicole Hayes, Health Habits for Summer

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

HEALTHY HABITS FOR A SUMMER OF WELLNESS 

 HEALTH AND WELLNESS EXPERT SHARES TIPS ON WAYS TO STAY HEALTHY THIS SEASON 

Now, more than ever, having a healthy routine is an important part of daily life. Many of us have taken to increased physical activity, eating healthier or incorporating vitamins and supplements to optimize our health, but as the summer months approach, we’re all looking for simple ways to stay on a track toward wellness. So my special guest for this show is Health and Wellness Expert Nicole Hayes and she is going to share how to maintain healthy habits all season long.

As a full-time working mom, with 3 children under 4, including a set of twins,

Nicole knows it can be tough to keep up a wellness routine. That’s why she fits it into her entire day, whether it’s running errands, taking trips to the park with her little ones, or going on a lunchtime walk at work. 

Being an insider at The Nature’s Bounty Co., Nicole is sure to know the best tips and tricks to incorporate wellness into your everyday routine. 

Tucson Business Radio

TMBS E100: Jim Francis, consumer law attorney

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

WERE YOU DAMAGED BY INACCURATE JUDGMENT OR LIEN INFORMATION ON YOUR CREDIT REPORT? 

 Learn How You Could Qualify for $1,500 from a Settlement with One of the Top Three Credit Reporting Agencies! 

Jim Francis is an accomplished consumer law attorney who works to protect consumers in federal and state courts in Pennsylvania and New Jersey.  Francis’ work at his firm, Francis Mailman Soumilas, P.C., focuses on fair credit reporting, fair debt collection practices, and consumer class actions.  He has served as Class counsel in over 35 consumer class actions, trial counsel in two class actions, and counsel to some of the largest Fair Credit Reporting Act (“FCRA”) settlements in history. 

He has published articles and spoken extensively about the FCRA. Francis appeared on various news programs, including the Today Show and PBS NewsHour to discuss consumer-related issues and was featured in The Philadelphia Inquirer.  Also, he currently serves on the Board of Directors of the National Association of Consumer Advocates (NACA). 

Francis has been recognized for his work in consumer protection litigation.  In 2004, Mr. Francis was the youngest lawyer to be ranked in the Top 100 Superlawyers in the Commonwealth of Pennsylvania in Philadelphia Magazine and Pennsylvania Super Lawyers magazine.   

He was subsequently ranked a Top 100 Pennsylvania Superlawyer in 2008, 2012, 2014-2018 and has regularly ranked one of the Top 100 Superlawyers in Philadelphia since 2004.  Also in May 2014, he received the Community Legal Services of Philadelphia’s Equal Justice Award at its annual Breakfast of Champions. He is a 1992 graduate of Muhlenberg College (B.A., cum laude) and a 1995 graduate of the Temple University Beasley School of Law.   

Tucson Business Radio

TMBS E99: Dr Denise Yardley, Good News for Cancer Patients

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

POSITIVE NEWS CONTINUES TO EMERGE FOR ADVANCED BREAST CANCER PATIENTS 

KISQALI EXPLORATORY SUBGROUP ANALYSIS FROM MONALEESA-3 AND MONALEESA-7, RESULTS ADD TO BODY OF OVERALL SURVIVAL EVIDENCE 

Denise Yardley, MD, Principal Investigator, Sarah Cannon Research Institute

There are approximately 155,000 individuals in the US are living with metastatic breast cancer. 

Up to 11% of new breast cancer cases are initially stage IV or metastatic. 

Nearly 30% of women initially diagnosed with the early-stage disease will ultimately develop metastatic lesions, often months or even years later.  

And as of 2017, in the United States, nearly 1 in 7 women with metastatic BC were younger than 50. ……Denise Yardley, MD, is the Principal Investigator for the Sarah Cannon Research Institute.

Indication 

KISQALI® (ribociclib) is a prescription medicine used in combination with:
• an aromatase inhibitor to treat pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic), as the first endocrine-based therapy; or
• fulvestrant to treat postmenopausal women with HR-positive, HER2-negative metastatic breast cancer as the first endocrine-based therapy or with disease progression following endocrine therapy. It is not known if KISQALI is safe and effective in children.
 

IMPORTANT SAFETY INFORMATION 

What is the most important information I should know about KISQALI? 

KISQALI may cause serious side effects, including: 

Lung problems. KISQALI may cause severe or life-threatening inflammation of the lungs during treatment that may lead to death. Tell your health care provider right away if you have any new or worsening symptoms, including: 

• trouble breathing or shortness of breath 

• cough with or without mucus 
• chest pain 

Heart rhythm problems (QT prolongation). KISQALI can cause a heart problem known as QT prolongation. This condition can cause an abnormal heartbeat and may lead to death. Your health care provider should check your heart and do blood tests before and during treatment with KISQALI. Tell your health care provider right away if you have a change in your heartbeat (a fast or irregular heartbeat), or if you feel dizzy or faint. 

 Liver problems (hepatobiliary toxicity). KISQALI can cause serious liver problems. Your health care provider should do blood tests to check your liver before and during treatment with KISQALI. Tell your health care provider right away if you get any of the following signs and symptoms of liver problems: 

• yellowing of your skin or the whites of your eyes (jaundice) 
• dark or brown (tea-colored) urine 
• feeling very tired 
• loss of appetite 
• pain on the right side of your stomach area (abdomen) 

• bleeding or bruising more easily than normal 

 Low white blood cell counts (neutropenia). Low white blood cell counts are very common when taking KISQALI and may result in infections that may be severe. Your health care provider should check your white blood cell counts before and during treatment with KISQALI. Tell your health care provider right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills. 

Your health care provider may tell you to decrease your dose, temporarily stop, or completely stop taking KISQALI if you develop certain serious side effects during treatment with KISQALI.  

 What should I tell my health care provider before taking KISQALI? 

Before you take KISQALI, tell your health care provider if you: 

• have any heart problems, including heart failure, irregular heartbeats, and QT prolongation 
• have ever had a heart attack 
• have a slow heartbeat (bradycardia) 
• have problems with the amount of potassium, calcium, phosphorus, or magnesium in your blood 
• have fever, chills, or any other signs or symptoms of infection 

• have liver problems  
• have any other medical conditions 
• are pregnant, or plan to become pregnant. KISQALI can harm your unborn baby 

• If you are able to become pregnant, your health care provider should do a pregnancy test before you start treatment with KISQALI. 
• Females who are able to become pregnant and who take KISQALI should use effective birth control during treatment and for at least 3 weeks after the last dose of KISQALI. 

• Talk to your health care provider about birth control methods that may be right for you during this time. 
• If you become pregnant or think you are pregnant, tell your health care provider right away. 

• are breastfeeding or plan to breastfeed. It is not known if KISQALI passes into your breast milk. Do not breastfeed during treatment with KISQALI and for at least 3 weeks after the last dose of KISQALI  

Tell your health care provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. KISQALI and other medicines may affect each other, causing side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine. 

What should I avoid while taking KISQALI?  

Avoid eating grapefruit and avoid drinking grapefruit juice during treatment with KISQALI since these may increase the amount of KISQALI in your blood. 

The most common side effects of KISQALI include: 

KISQALI may cause fertility problems if you are male and take KISQALI. This may affect your ability to father a child. Talk to your health care provider if this is a concern for you. 

Tell your health care provider if you have any side effect that bothers you or that does not go away. 

These are not all of the possible side effects of KISQALI. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. 

Please see accompanying full Prescribing Information. 

References 

1. Yardley, Denise, A. et. al. Overall survival (OS) in patients (pts) with advanced breast cancer (ABC) with visceral metastases (Mets), including those with liver Mets, treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA (ML) -3 and -7 trials. Presented at the American Society of Clinical Oncology (ASCO) meeting (Abstract #1054). 

1. Wang, R., Zhu, Y., Liu, X. et al. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer 19, 1091 (2019). 

1. National Cancer Institute. Dictionary of Cancer Terms. Available at:  https://www.cancer.gov/publications/dictionaries/cancer-terms/def/visceral. Accessed November 2018. 

Tucson Business Radio

TMBS E98: Oriaku Njoku, Abortion Restrictions Stricken

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

IMPACT OF SUPREME COURT DECISION STRIKING DOWN ABORTION RESTRICTIONS  

ORIAKU NJOKU — NATIONAL EXPERT ON ABORTION ACCESS & EXECUTIVE DIRECTOR of ACCESS REPRODUCTIVE CARE-SOUTHEAST explains the impact of Supreme Court decision and barriers to abortion care that remain 

 Washington D.C.—In a recent decision, the Supreme Court struck down a Louisiana law designed to shut down abortion clinics, meaning states cannot enact abortion restrictions under the guise of patient safety and health and clinics in Louisiana can stay open. 

 But this ruling is just the beginning — the legal right to abortion is the floor, not the ceiling. Advocates are mobilizing to ensure everyone has the abortion care they need in their communities and end the restrictions that push care out of reach even with the right to abortion in place.  

The Supreme Court’s decision comes as threats to legal abortion in the United States have never been greater. Many women, and especially those struggling to make ends meet who are disproportionately women of color, will continue to face barriers to care, especially amid an increasingly hostile political climate:

• The decision comes amid a global pandemic that also disproportionately impacts communities of color, including Black women. Anti-abortion politicians have tried to exploit the pandemic to push even more restrictions and bans on abortion care; 

• Since 2011, states have passed more than 400 laws restricting abortion — forcing clinics to close and placing medically unnecessary barriers in front of people seeking care. Last year saw an unprecedented wave of abortion bans passed in the South and Midwest.

• In 2019, an estimated 29 independent abortion clinics were forced to shut down, while 136 have shuttered since 2014. 

• The impact of abortion restrictions falls hardest on people struggling financially, especially women of color, young people, rural and immigrant communities, and LGBTQ individuals. 

Oriaku Njoku is the co-founder and executive director of Access Reproductive Care – Southeast, which provides funding and logistical support for Georgians and women across the region who cannot afford to pay for their abortion care. She is a national expert on abortion access and the impact of restrictions on Black women and communities of color and serves on the board of the National Network of Abortion Funds and ReproAction. 

Tucson Business Radio

TMBS 97: Claire Whittaker, Artificially Intelligent Consulting

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

Claire Whittaker, Artificially Intelligent Consulting
www.artificiallyintelligentconsulting.com
https://calendly.com/driveit/mini-coaching-session
SOCIAL MEDIA: Facebook | LinkedIn |

Claire Whittaker business systems and automation coach and the founder of Artificially Intelligent Consulting. Artificially Intelligent Consulting owned and operated by Claire Whittaker helps business owners to implement systems that inspire them instead of stressing them out so that they can double their revenue without working extra hours. 

After a while, Claire wanted something more fast-paced and that was when she joined Amazon.  Initially, in account management, she moved across a variety of roles eventually working on projects and launching products using artificial intelligence across Europe, India, and Japan. 

Now as a certified SME consultant, Claire is working with small businesses, sharing the framework that helped you drive consistent, sustainable growth without getting overwhelmed. Her signature program DRIVE Together helps business owners identify and implement systems to double revenue without working extra hours. 

Tucson Business Radio

TMBS E96: College Board Lacey Allen

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

Guide Students Through The Admissions Process And Earn Money For College With The College Board Opportunity Scholarships

Lacey Allen is an Associate Director for the College Board Opportunity Scholarships, a program that awards $5 million dollars each year to high school students.  
 
Lacey previously worked at Search Institute, a youth development research organization, as a qualitative researcher and facilitator.  
 
She also served in both the Peace Corps and AmeriCorps; while in Morocco with the Peace Corps, Lacey volunteered with NGOs and US-based nonprofits to develop literacy tools, resources, and a library for youth in community centers, and while with AmeriCorps, Lacey worked to improve college access opportunities for first-generation high school students.  
 
Lacey has an M.Ed. in Youth Development Leadership and a B.A. in Communication. 

Tucson Business Radio

TMBS E95: Guillermo Miranda, IBM Corporate Social Respons.

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

More About Guillermo Miranda: 

Global Head, IBM Corporate Social Responsibility 

https://www.linkedin.com/in/digitalmirandag/ 

 In this role, Guillermo leads IBM’s responsible stewardship and social impact programs worldwide. IBM has long been a leader in setting new business standards and in taking social stands on important issues. Guillermo is working to expand IBM’s strong history of social impact by prioritizing investments to tackle societal challenges like reinventing education for the AI / Digital driven economy. He has made significant investments to drive systemic change on how IBM approaches its social purpose, in particular reinventing how IBMers give and engage with the communities in which they live and work. 

 Guillermo brings a vast international perspective and employee-centered mindset to corporate responsibility. Since 1997, Guillermo has served IBM in various leadership roles around the world, beginning in Peru and extending across Europe, Latin America, North America, Africa, and the Middle East. He is fluent in Spanish, English, and Portuguese. 

 He has held several senior leadership roles at the company including IBM’s Chief Learning Officer, People & Talent Head for the Digital Business Group, Regional HR VP for Africa & Middle East, among others. Prior to joining IBM, he served as the Chief Human Resources Officer of the InterAmerican Development Bank and the Peruvian Tax Agency (SUNAT). 

 Guillermo is the founding Chair of the Digital Learning Consortium, serves on the Board of Directors of IPCOM Global LLC. and is a member of the Advisory Board of the Digital Marketing Institute. He holds an MBA from Deusto University (Spain), and a Law degree from the Pontificia Universidad Católica del Perú. He and his family live near Washington, D. C.